Skip to main content

stemcentrx-logo

In 2002, Scott Dylla, a skinny postdoc with a Minnesota accent, answered a Craigslist ad for a room for rent in Palo Alto. Although he couldn’t afford to move in with Brian Slingerland, then an up-and-coming technology banker at Credit Suisse, the two got to talking.

Two of Slingerland’s aunts had died of cancer. One, only a year after she retired. The other of lung cancer. She’d always smoked Kents.

{iframe}http://www.technologyreview.com/news/541006/peter-thiel-backs-biotech-unicorn-fighting-cancer-stem-cells/?utm_campaign=newsletters&utm_source=newsletter-daily-all&utm_medium=email&utm_content=20150908{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.